Grab Gold While oil was on the decline last month, the price of gold ticked above $1,590 per ounce to reach its highest level in seven years. However, that is still far below its peak price of more than $2,000 achieved in August 2011. Few countries still adhere to a gold standard for their currencies. However, gold is still universally regarded as a hedge against fluctuations in the value of the U.S. dollar. It is also viewed as a store of value that can be relied upon during times of global upheaval. The ProShares Ultra Gold (UGL) ETF is a cheap and easy way to participate in rising gold prices. This fund is designed to move twice as much in the same direction as the price of gold. Last week, UGL increased 3% in value while the stock market fell by a similar amount. Buy Biotech The ETFs described above should provide short-term portfolio protection against the coronavirus. However, if the coronavirus is not quickly contained, there will be a need for a cure to treat current victims and a vaccine to prevent further spread. You can make a sweeping bet on the entire biotech sector by owning the iShares Nasdaq Biotechnology ETF (IBB). Surprisingly, this fund's share price fell last week while fear of the coronavirus rose. Presumably, the stock market does not yet believe that this outbreak will result in the need for a new treatment. But if it does, the fund could quickly spike in value. Editor's Note: Our colleague Jim Pearce just put a spotlight on a global health crisis. But did you know that there's a new cure for the most common affliction that hurts older Americans? This affliction isn't the coronavirus. Nor is it cancer, Alzheimer's, or diabetes. One in five adults suffer from this affliction. That's around 50 million in the U.S. alone. And until recently, all of the treatments had MAJOR side effects. (In fact, they're about to become illegal.) Which means the one biotech stock tied to this new cure for chronic pain could quickly skyrocket by as much as 4,450% or more. You've probably never heard of the company. Wall Street analysts are ignoring it. But our investment experts have uncovered this hidden biotech gem and now's the time to invest. You need to act quickly, before the rest of the investment herd catches on and bids the share price sky high. Click here for details. |
Tidak ada komentar:
Posting Komentar